These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 16196502)
1. Oncogenes as novel targets for cancer therapy (part III): transcription factors. Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H Am J Pharmacogenomics; 2005; 5(5):327-38. PubMed ID: 16196502 [TBL] [Abstract][Full Text] [Related]
2. Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling molecules. Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H Am J Pharmacogenomics; 2005; 5(4):247-57. PubMed ID: 16078861 [TBL] [Abstract][Full Text] [Related]
3. Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosis. Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H Am J Pharmacogenomics; 2005; 5(6):397-407. PubMed ID: 16336004 [TBL] [Abstract][Full Text] [Related]
4. Oncogenes as novel targets for cancer therapy (part I): growth factors and protein tyrosine kinases. Zhang Z; Li M; Rayburn ER; Hill DL; Zhang R; Wang H Am J Pharmacogenomics; 2005; 5(3):173-90. PubMed ID: 15952871 [TBL] [Abstract][Full Text] [Related]
5. Transcription factors as drug targets in cancer. Hurst HC Eur J Cancer; 1996 Oct; 32A(11):1857-63. PubMed ID: 8943667 [TBL] [Abstract][Full Text] [Related]
6. A stochastic model of oncogene expression and the relevance of this model to cancer therapy. Alfano FD Theor Biol Med Model; 2006 Jan; 3():5. PubMed ID: 16448558 [TBL] [Abstract][Full Text] [Related]
8. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Comoglio PM; Giordano S; Trusolino L Nat Rev Drug Discov; 2008 Jun; 7(6):504-16. PubMed ID: 18511928 [TBL] [Abstract][Full Text] [Related]
10. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation. Liebermann DA; Hoffman B Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003 [TBL] [Abstract][Full Text] [Related]
11. The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Castillo SD; Sanchez-Cespedes M Expert Opin Ther Targets; 2012 Sep; 16(9):903-19. PubMed ID: 22834733 [TBL] [Abstract][Full Text] [Related]
12. Oncogenes: cause or consequence in the development of glial tumors. Akbasak A; Sunar-Akbasak B J Neurol Sci; 1992 Sep; 111(2):119-33. PubMed ID: 1331337 [TBL] [Abstract][Full Text] [Related]
13. Report of a meeting: molecular basis of cancer therapy. Gottesman MM J Natl Cancer Inst; 1994 Sep; 86(17):1277-85. PubMed ID: 7914937 [TBL] [Abstract][Full Text] [Related]
14. Antagonistic functional duality of cancer genes. Stepanenko AA; Vassetzky YS; Kavsan VM Gene; 2013 Oct; 529(2):199-207. PubMed ID: 23933273 [TBL] [Abstract][Full Text] [Related]